Jiang Bian, Ph.D.
Jiang Bian, Ph.D., was appointed chief research information officer for UF Health. In this new capacity, Bian will focus on advancing the operations and governance of information technology in support of research activities across the UF Health enterprise, in close partnership with other senior leaders. He also will continue to serve as UF Health chief data scientist.
Jonathan D. Licht, M.D.
Jonathan D. Licht, M.D., presented a lecture, titled “Histone Modifications as Cancer Drivers,” during the Cancer Genetics and Epigenetics Gordon Research Conference held May 21-26 in Italy.
Piyush Jain, Ph.D.
Piyush Jain, Ph.D., received the UF Herbert Wertheim College of Engineering 2023 Excellence Award for Assistant Professors.
Brian Ramnaraign, M.D.
Brian Ramnaraign, M.D., received a fall 2023 Faculty Enhancement Opportunity Award to attend courses on Cancer Genomics and Precision Oncology, Immuno-oncology, Drug Delivery, Drug Discovery and Development, and Clinical Drug Development from Harvard Medical School.
Bently Doonan, M.D., Ashley Ghiaseddin, M.D., and Maryam Rahman, M.D.
Bently Doonan, M.D., Ashley Ghiaseddin, M.D., and Maryam Rahman, M.D., gave presentations during a UF Health Wellness University event, titled “Unraveling the Mysteries of Cancer,” on Friday, May 5 at The Brownwood Hotel in The Villages.
Raymond Mailhot, M.D., M.P.H.
Raymond Mailhot, M.D., presented “Cost Effectiveness of Hypofractionated Proton Therapy” on May 7 during the 2023 National Proton Conference in Salt Lake City.
Jonathan Chatzkel, M.D., William Donelan, Ph.D., Sara Falzarano, M.D., Padraic O’Malley, M.D., FRCSC, Brian Ramnaraign, M.D., Li-Ming Su, M.D., FRCS, and Robert Zlotecki, M.D., Ph.D.
Jonathan Chatzkel, M.D., William Donelan, Ph.D., Sara Falzarano, M.D., Padraic O’Malley, M.D., FRCSC, Brian Ramnaraign, M.D., Li-Ming Su, M.D., FRCS, and Robert Zlotecki, M.D., Ph.D., gave presentations during the Celebrating Hope Kidney Cancer Educational Symposium sponsored by the Judy Nicholson Kidney Cancer Foundation and the UF Health Cancer Center on May 15.
HOBI research team
A HOBI research team co-led by Jennifer LeLaurin, Ph.D. and Kathryn Pluta, Ph.D., was selected for the 2023 Consortium for Cancer Implementation Science (CCIS) award program funded by the National Cancer Institute (NCI). Pluta is a HOBI postdoctoral associate who works closely with Ramzi Salloum, Ph.D. He is serving as a mentor for this project along with Naykky Singh Ospina, M.D. The project supports the ongoing efforts of the CCIS to develop a collection of public goods to address key challenges and advance the implementation science agenda in cancer.
Olga Guryanova, M.D., Ph.D.
Olga Guryanova, M.D., Ph.D., gave a presentation, titled “Leukemia-associated mutations in DNMT3A: from clonal hematopoiesis to therapy response,” during the Erasmus MC Virtual Hematology Lecture series on May 15.
Thomas Schmittgen, Ph.D., Fan Zhang, Ph.D., and Guangrong Zheng, Ph.D.
Thomas Schmittgen, Ph.D., received the Outstanding Basic Science Research Award from the University of Florida College of Pharmacy during its annual faculty award ceremony. Fan Zhang, Ph.D., was honored as part of the Outstanding Teaching Team Year 1. Guangrong Zheng, Ph.D., received the Research Impact Award.
Laura Solt, Ph.D.
Laura Solt, Ph.D., received a $306,921 grant from the National Institute of Diabetes and Digestive and Kidney Diseases, titled “Ligand-Dependent Regulation of the Nuclear Receptor REV-ERBa in TH17 Cell Development and Inflammation.”
Helen Moore, Ph.D.
Helen Moore, Ph.D., was elected to a two-year term as the vice chair of the Society for Industrial and Applied Mathematics Life Sciences Activity Group.
Kate Carroll, Ph.D.
Kate Carroll, Ph.D., received a $205,000 grant from the National Institute of General Medical Sciences, titled “Chemical Tools for Probing Cysteine Sulfenation and Sulfination Redox Biology.”
Michalina Janiszewska, Ph.D.
Michalina Janiszewska, Ph.D., received a Best Mentor Award during Research Fest at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology.
Linda B. Cottler, Ph.D.
Linda B. Cottler, Ph.D., recently began her second term as president of the Board of Directors for the Association for Clinical and Translational Science (ACTS). Founded in 2009 to support the needs of the national Clinical and Translational Science Awards program, ACTS represents nearly 5,000 members who are involved in academic institutions, industry, philanthropic agencies and government. It supports multidimensional, cross-cutting research that encompasses multidisciplinary investigative teams from many subspecialty areas.